Skip to content
PICO Portalanswers from OpenAlex

ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24− phenotype

PaperCitations, authors & open-access status

ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24− phenotype is a paper indexed in PICO Portal from OpenAlex.

How many citations does ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24− phenotype have?

PICO Portalcitation count

ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24− phenotype has 54 citations in the OpenAlex counts PICO Portal stores.

When was ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24− phenotype published?

PICO Portalyear

ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24− phenotype has 2014 year in the PICO Portal index.

What is the open-access status of ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24− phenotype?

PICO Portaloa status

ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24− phenotype has closed oa status in the PICO Portal index.

What is the DOI of ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24− phenotype?

PICO Portaldoi

The DOI for ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24− phenotype is on the source record.

What is the PMID of ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24− phenotype?

PICO Portalpmid

The PMID for ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24− phenotype is on the source record.

What is the OpenAlex record for ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24− phenotype?

PICO Portalopenalex

The OpenAlex for ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24− phenotype is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial